|   |
"#ffffff" align="center" colspan="2"
|
|   |
"center" colspan="2" ''1,4-dihydro-1-cyclopropyl-6-fluoro-<BR>4-oxo-7-(1-piperazinyl)-<BR>3-quinolinecarboxylic acid''
|
|   |
"center" style="border-bottom: 3px solid gray"
|
|   |
"http://wwwinformationdelightinfo/encyclopedia/entry/CAS_number" class="copylinks">CAS Number ''' <br/> 85721-33-1
|
|   |
"http://wwwinformationdelightinfo/encyclopedia/entry/ATC_code" class="copylinks">ATC Code ''' <br/> J01MA02, S01AX13, S03AA07
|
|   |
"#eeeeee" Chemical Formula
|
|   |
"#ddeeff" C<sub>17</sub>H<sub>18</sub>FN<sub>3</sub>O<sub>3</sub>
|
|   |
"#eeeeee" Molecular Weight
|
|   |
"#ddeeff" 331345
|
|   |
"#eeeeee" Bioavailability
|
|   |
"#ddeeff" 69%Drusano GL, Standiford HC, Plaisance K, Forrest A, Leslie J, Caldwell J ''Absolute oral bioavailability of ciprofloxacin'' Antimicrob Agents Chemother 198630:444-6 PMID 3777908
|
|   |
"#eeeeee" Metabolism
|
|   |
"#ddeeff" Hepatic, including CYP1A2
|
|   |
"#eeeeee" Elimination Half-life
|
|   |
"#ddeeff" 4 hours
|
|   |
"#eeeeee" Excretion
|
|   |
"#ddeeff" Renal
|
|   |
"#eeeeee" Pregnancy Category
|
|   |
"#ddeeff" B3 (Australia)
|
|   |
"#eeeeee" Legal Status
|
|   |
"#ddeeff" Schedule 4 (Australia)
|
|   |
"#eeeeee" Routes of administration
|
|   |
"#ddeeff" Oral, intravenous, topical (ear drops, eye drops)
|